Showing results (111-120 of 116) with videos related to
Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 116 results.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 20, 1998
Comparing outcomes in renal replacement therapy: how should we correct for case mix?I H Khan, M K Campbell, D Cantarovich, et al.European Journal of Medicinal Chemistry|April 16, 2021
Azetidinimines as a novel series of non-covalent broad-spectrum inhibitors of β-lactamases with submicromolar activities against carbapenemases KPC-2 (class A), NDM-1 (class B) and OXA-48 (class D)Eugénie Romero, Saoussen Oueslati, Mohamed Benchekroun, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 9, 2000
Evaluation of clinical guidelines for the management of end-stage renal disease in europe: the EU BIOMED 1 studyC R Ramsay, M K Campbell, D Cantarovich, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 1, 1996
Survival on renal replacement therapy in Europe: is there a 'centre effect'?I H Khan, M K Campbell, D Cantarovich, et al.Nature Communications|March 18, 2018
A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockageMarcus J G W Ladds, Ingeborg M M van Leeuwen, Catherine J Drummond, et al.Nature Communications|May 24, 2018
Publisher Correction: A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockageMarcus J G W Ladds, Ingeborg M M van Leeuwen, Catherine J Drummond, et al.Pageof 12